期刊文献+

抗生素缓控释给药系统——载药微球的研究与开发 被引量:4

Drug-loaded Microspheres as Sustained/Controlled-Release Drug Delivery System for Antibiotics:Research and Development
原文传递
导出
摘要 利用具良好生物相容性和生物可降解性的聚合物制得的微球作为一种新型药物载体,具有良好的缓控释作用,并具有一定的靶向性,可用于口服和注射,在药学领域和临床上有着广阔的应用前景。综述近年来各种抗生素缓控释微球制剂的研究与开发。 As a new type of drug carrier, the microspheres prepared using the polymers with good biocompatiblility and biodegradablity possess the desired sustained/controlled-release and some targeting properties, being suitable tbr oral and injection administration; theretbre they have a broad application prospect in the pharmaceutical filed and in a clinical practice. The research and development of sustained/controlled-release microsphere formulations for various antibiotics in recent years have been reviewed.
作者 郑珩 顾觉奋
出处 《药学进展》 CAS 2014年第11期824-828,共5页 Progress in Pharmaceutical Sciences
关键词 抗生素 微球 缓控释给药系统 antibiotics microsphere sustained/controlled-release drug delivery system
  • 相关文献

参考文献19

二级参考文献86

共引文献24

同被引文献57

  • 1霍美蓉,周建平,魏彦,吕霖.紫杉醇阳离子壳聚糖胶束的制备及其在小鼠体内的组织分布[J].中国药科大学学报,2006,37(2):132-136. 被引量:20
  • 2郁晓,任杰,任天斌,袁华.两性霉素B缓释微球的制备及缓释性能研究[J].中国生物医学工程学报,2007,26(3):445-451. 被引量:10
  • 3Ascens~o A, Oliveira P J, Magalhaes J. Exercise as a beneficial adjunct therapy during Doxorubicin treatment- Role of mitochondria in cardioprotection[J]. Int J Cardiol, 2012, 156(1): 4-10.
  • 4Octavia Y, Tocchetti CG, Gabrielson KL, et al. Doxorubicin- induced cardiomyopathy: From molecular mechanisms to therapeutic strategies[J]. J Mol Cell Cardiol, 2012, 52(6): 1213-1225.
  • 5Carvalho FS, Burgeiro A, Garcia R, et al. Doxorubicin- induced cardiotoaicity: From bioenergetic failure and cell death to cardiomyopathy[J]. Med Res Rev, 2014, 34(1): 106- 135.
  • 6Xi L, Zhu S G, Das A, et al. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: Mechanisms and implications[J]. Nitric Oxide, 2012, 26(4): 274-284.
  • 7Cascales A, Sanchez-Vega B, Navarro N, et al. Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation[J]. Int J Cardiol, 2012, 154(3): 282-286.
  • 8Yun CH, Chae H J, Kim HR, et al. Doxorubicin - and daunorubicin - induced regulation of Ca^2+ and H^+ fluxes through human bax inhibitor - 1 reconstituted into membranes[J]. J Pharm Sci, 2012, 101 (3): 1314-1326.
  • 9Palmeira CM, Moreno AJ. Mitochondrial bioenergetics[M]. Methods and Protocols. Springer Methods in Molecular Biology, 2012年.
  • 10Vavrova A, Jansova H, Mackova E, et al. Catalytic inhibitors of topoisomerase Ⅱ differently modulate the toxicity of anthracyclines in cardiac and cancer cells[J]. PLoS ONE, 2013, 8(10): e76676.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部